Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -818 | -2,667 | -1,801 | -1,597 | -963 |
| Depreciation Amortization | 1 | 323 | 308 | 135 | 92 |
| Other Working Capital | 617 | 308 | -352 | 464 | 157 |
| Other Operating Activity | 14 | 232 | 196 | 69 | 23 |
| Operating Cash Flow | $-187 | $-1,804 | $-1,649 | $-930 | $-691 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -5 | -32 | -30 | -22 | -22 |
| Other Investing Activity | -5 | -32 | -30 | -22 | -22 |
| Investing Cash Flow | $-5 | $-32 | $-30 | $-22 | $-22 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 1,381 | 1,381 | 1,381 | 1,381 |
| Common Stock Issued | 50 | 678 | 600 | 0 | N/A |
| Financing Cash Flow | $50 | $2,059 | $1,981 | $1,381 | $1,381 |
| Beginning Cash Position | 295 | 72 | 72 | 72 | 72 |
| End Cash Position | 154 | 295 | 374 | 501 | 740 |
| Net Cash Flow | $-142 | $223 | $302 | $428 | $667 |
| Free Cash Flow | |||||
| Operating Cash Flow | -187 | -1,804 | -1,649 | -930 | -691 |
| Free Cash Flow | -187 | -1,804 | -1,649 | -930 | -691 |